» Articles » PMID: 34934042

Single-cell Transcriptomic Analysis Reveals the Critical Molecular Pattern of UV-induced Cutaneous Squamous Cell Carcinoma

Overview
Journal Cell Death Dis
Date 2021 Dec 22
PMID 34934042
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous squamous cell carcinoma (cSCC) is the second most common nonmelanoma skin cancer characterized by high invasiveness, heterogeneity, and mainly occurs in the ultraviolet (UV)-exposed regions of the skin, but its pathogenesis is still unclear. Here, we generated single-cell transcriptome profiles for 350 cells from six primary UV-induced cSCCs, together with matched adjacent skin samples, and three healthy control skin tissues by single-cell RNA-sequencing technology based on Smart-seq2 strategy. A series of bioinformatics analyses and in vitro experiments were used to decipher and validate the critical molecular pattern of cSCC. Results showed that cSCC cells and normal keratinocytes were significantly distinct in gene expression and chromosomal copy number variation. Furthermore, cSCC cells exhibited 18 hallmark pathways of cancer by gene set enrichment analysis. Differential expression analysis demonstrated that many members belonging to S100 gene family, SPRR gene family, and FABP5 were significantly upregulated in cSCC cells. Further experiments confirmed their upregulation and showed that S100A9 or FABP5 knockdown in cSCC cells inhibited their proliferation and migration through NF-κB pathway. Taken together, our data provide a valuable resource for deciphering the molecular pattern in UV-induced cSCC at a single-cell level and suggest that S100A9 and FABP5 may provide novel targets for therapeutic intervention of cSCC in the future.

Citing Articles

Effect of catalase on CPC production during fermentation of Acremonium chrysogenum.

Liu L, Chen Z, Tian X, Chu J Bioresour Bioprocess. 2025; 12(1):1.

PMID: 39753989 PMC: 11699191. DOI: 10.1186/s40643-024-00831-y.


Unraveling the landscape of non-melanoma skin cancer through single-cell RNA sequencing technology.

Yan G, Wang X, Zhang G Front Oncol. 2024; 14:1500300.

PMID: 39558960 PMC: 11570581. DOI: 10.3389/fonc.2024.1500300.


Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis.

Ma Z, An P, Hao S, Huang Z, Yin A, Li Y Front Immunol. 2024; 15:1374763.

PMID: 38596682 PMC: 11002082. DOI: 10.3389/fimmu.2024.1374763.


Disruption of H3K36 methylation provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis.

Ko E, Anderson A, Dsouza C, Zou J, Huang S, Cho S Dev Cell. 2024; 59(2):187-198.e7.

PMID: 38198888 PMC: 10872381. DOI: 10.1016/j.devcel.2023.12.007.


Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease.

Kang Z, Jiang L, Chen D, Yan G, Zhang G, Lai Y Skin Res Technol. 2023; 29(10):e13497.

PMID: 37881057 PMC: 10579628. DOI: 10.1111/srt.13497.


References
1.
Thompson A, Kelley B, Prokop L, Murad M, Baum C . Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis. JAMA Dermatol. 2016; 152(4):419-28. PMC: 4833641. DOI: 10.1001/jamadermatol.2015.4994. View

2.
Karia P, Han J, Schmults C . Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013; 68(6):957-66. DOI: 10.1016/j.jaad.2012.11.037. View

3.
Ratushny V, Gober M, Hick R, Ridky T, Seykora J . From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest. 2012; 122(2):464-72. PMC: 3266779. DOI: 10.1172/JCI57415. View

4.
Migden M, Rischin D, Schmults C, Guminski A, Hauschild A, Lewis K . PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2018; 379(4):341-351. DOI: 10.1056/NEJMoa1805131. View

5.
Grob J, Gonzalez R, Basset-Seguin N, Vornicova O, Schachter J, Joshi A . Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629). J Clin Oncol. 2020; 38(25):2916-2925. PMC: 7460151. DOI: 10.1200/JCO.19.03054. View